HAVCR2 and glioma: A very recent publication identified enhanced percentage of TIM-3 positivity on tumor-infiltrating immune cells in both myeloid and lymphoid compartments from pilocytic astrocytoma (the most common pediatric glioma) patients compared with matched patient PBMCs and healthy control PBMCs [107].